← Browse by Condition
Medical Condition
lung infection
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for lung infection sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
NCT05973201
Recruiting
Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)
Enrollment
120 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT03236987 Phase 3
Recruiting
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
Enrollment
424 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
NCT06528418
Recruiting
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Enrollment
10,000 pts
Location
China
Sponsor
ChromX Health
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology